Oral Aspirin is Preferred for Acute Myocardial Infarction
For acute myocardial infarction, oral (peroral) aspirin should be administered as the standard route, with intravenous aspirin reserved only for patients who cannot take oral medication. The most recent 2025 ACC/AHA guidelines explicitly state that aspirin should be initiated with an oral loading dose (162-325 mg) as soon as possible on presentation, with IV administration listed only as an option when patients cannot take oral medication 1.
Recommended Dosing Strategy
Initial Loading Dose
- Oral aspirin 162-325 mg should be chewed (non-enteric coated) for faster buccal absorption 1, 2
- Administer immediately upon presentation, regardless of whether invasive or noninvasive strategy is planned
- Give loading dose even if patient is already on chronic aspirin therapy 1
Alternative Route (When Oral Not Possible)
- IV aspirin 250 mg can be used if oral ingestion is impossible 3
- Rectal administration is another alternative 1
Maintenance Therapy
- 75-100 mg daily (non-enteric coated) continued indefinitely 1
- This low-dose maintenance is superior to higher doses (300-325 mg), which increase bleeding without improving outcomes 1
Why Oral is Standard Despite IV Pharmacodynamics
While research shows IV aspirin achieves faster and more complete platelet inhibition at 5-20 minutes compared to oral 4, 5, this pharmacodynamic advantage does not translate into clinical benefit. The 2023 meta-analysis found no significant difference between IV and oral aspirin in:
- Composite cardiovascular death, stroke, and MI at 4-6 weeks
- All-cause mortality
- Cardiovascular mortality
- Stroke occurrence
- MI/reinfarction rates 5
Critical caveat: One retrospective study found higher in-hospital mortality (9.3% vs 6.0%) with high-dose IV aspirin (≥483 mg) compared to oral aspirin, suggesting potential harm from excessive IV dosing 6. This reinforces guideline recommendations to use standard oral dosing.
Practical Algorithm
Step 1: Can patient swallow and absorb oral medication?
- YES → Give 162-325 mg chewable (non-enteric) aspirin immediately
- NO → Proceed to Step 2
Step 2: Is IV access established?
Step 3: Transition to maintenance
- Start 75-100 mg daily oral aspirin (non-enteric coated) within 24 hours
- Continue indefinitely unless contraindicated
Key Pitfalls to Avoid
Do not use enteric-coated aspirin initially - delayed and reduced absorption makes it inappropriate for acute settings 7, 8, 2
Do not use high-dose IV aspirin - doses >300 mg IV may increase mortality without benefit 6
Do not continue high-dose maintenance - after initial loading, switch to 75-100 mg daily; doses ≥160 mg increase bleeding without improving outcomes 7
Do not delay aspirin for "better" IV effect - oral aspirin works sufficiently fast when chewed, and guidelines prioritize immediate administration over route optimization 1
The evidence hierarchy is clear: multiple Class I, Level A guideline recommendations support oral aspirin as first-line 7, 1, 2, 9, with IV aspirin mentioned only as an alternative when oral route is unavailable. The faster platelet inhibition with IV does not justify routine use given equivalent clinical outcomes and potential safety concerns with higher IV doses.